High expectations are placed upon anti-angiogenic compounds for metastatic colorectal
cancer (mCRC), the first malignancy for which such type of treatment has been approved …

Background Colorectal cancer (CRC) is a common cancer worldwide. The main cause of
death in CRC includes tumor progression and metastasis. At molecular level, these …

Cervical cancer (CC) is the most common cancer in women in the lower genital tract. The
main risk factor for developing CC is persistent infection with HPV 16. The E6 and E7 …

Colorectal cancer (CRC) treatment primarily relies on chemotherapy along with surgery,
radiotherapy and, more recently, targeted therapy at the late stages. However …

Background Biological markers expressed in cancer cells and the surrounding cancer-
associated fibroblasts (CAF) can be used for prediction of patient prognosis in colorectal …

Glioma is a common malignant tumour of the brain. In this study, we aimed to investigate
diagnostic biomarkers and its role in glioma. Weighted gene co‐expression network …

Colorectal cancer (CRC) is regarded as the third most common cancer worldwide. Although
Regorafenib as a receptor tyrosine kinase inhibitor (RTKI) disrupts tumor growth and …

One of the factors contributing to colorectal cancer (CRC) development is inflammation,
which is mostly hypoxia-associated. This study aimed to characterize the morphological and …

Objective: Metastasis phenotype is considered as the main challenge in colon cancer
therapeutic methods. Furthermore, the side effects of conventional colorectal cancer …

Human papillomavirus 16 (HPV 16) infection is associated with several types of cancer,
such as head and neck, cervical, anal, and penile cancer. Its oncogenic potential is due to …